Inflammatory bowel disease meets fertility: A physician and patient survey
- PMID: 36697343
- DOI: 10.1016/j.dld.2023.01.149
Inflammatory bowel disease meets fertility: A physician and patient survey
Abstract
Background and aims: Inflammatory bowel disease (IBD) can affect patients during their childbearing years. Literature evidence is scarce regarding the level of knowledge among health care professionals (HCPs) and patients about the impact of IBD on fertility. The aim of this survey was to investigate HCPs' and patients' knowledge on fertility, pregnancy, and sexual function, to evaluate how HCPs approach this topic and to report patients' reproductive outcomes.
Methods: Subjects were invited to anonymously complete an online questionnaire collecting data on demographics, patients' disease characteristics, Crohn's and colitis pregnancy-specific disease-related knowledge (CCPKnow), family planning, reason of childlessness, pregnancy outcomes, need for assisted reproductive technology, impact on sexual function, and availability of patients' information regarding IBD and pregnancy.
Results: A total of 257 HCPs from 40 countries and 793 patients (615 females, 176 males and 2 who preferred not to disclose their gender; 396 (50%) with ulcerative colitis, 381 (48%) with Crohn's disease, 14 (1.8%) with undetermined IBD) from 4 countries completed the survey. In total, 98.4% of HCPs had good or very good pregnancy-specific knowledge according to CCPKnow score, compared to only 29.3% of patients. Of the women surveyed, 56.3% had no children (14.1% due to a voluntary choice). A total of 427 pregnancies and 401 live births were reported in 266 women. Twenty-four pregnancies (5.6%) in 22 women required assisted reproductive technologies (ART). There were no more complications in pregnancies resulting from ART compared with spontaneous conception (5/24; 20.8% vs 81/401; 20.2%). Three quarters of IBD patients (75.6%) had breastfed. An impaired sexual function was found in one-fifth (21.9%) of men with IBD, while two-thirds (66.1%) of the women reported sexual function impairment. Surprisingly, 63% of patients reported not having received any information about IBD and pregnancy, and only 10% of patients had received information from their IBD specialist. In addition, 42.1% and 36% of HCPs had already referred a patients to a medically assisted reproduction center to receive general information about their reproductive health and about options of fertility preservation (e.g., cryopreservation), respectively.
Conclusion: IBD patients have a poor knowledge about the impact of IBD on fertility and pregnancy and HCPs do not sufficiently inform their patients. More information on these topics is needed for IBD patients.
Keywords: CCPKnow score; Fertility; Inflammatory bowel disease.
Copyright © 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of interest S Vieujean declares no conflict of interest. M De Vos has received speaker fees from Ferring, Merck, Gedeon Richter, Organon and Cooper Surgical. F D'Amico has served as a speaker for Janssen, Galapagos, Sandoz, and Omega Pharma. R Dudkowiak declares no conflict of interest. S Danese has served as a speaker, consultant, and advisory board member for Schering-Plough, AbbVie, Actelion, Alphawasserman, AstraZeneca, Cellerix, Cosmo Pharmaceuticals, Ferring, Genentech, Grunenthal, Johnson and Johnson, Millenium Takeda, MSD, NikkisoEurope GmbH, Novo Nordisk, Nycomed, Pfizer, Pharmacosmos, UCB Pharma and Vifor. L Peyrin-Biroulet : personal fees from Galapagos, AbbVie, Janssen, Genentech, Ferring, Tillots, Pharmacosmos, Celltrion, Takeda, Boerhinger Ingelheim, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Inotrem, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen, BMS, Vifor, Norgine ; Mylan, Lilly, Fresenius Kabi, Oppilan Pharma, Sublimity Therapeutics, Applied Molecular Transport, OSE Immunotherapeutics, Enthera, Theravance ; Pandion Therapeutics, grants from Abbvie, MSD, Takeda, Fresenius Kabi, stock options : CTMA.
Similar articles
-
What Factors Might Drive Voluntary Childlessness (VC) in Women with IBD? Does IBD-specific Pregnancy-related Knowledge Matter?J Crohns Colitis. 2016 Oct;10(10):1151-8. doi: 10.1093/ecco-jcc/jjw078. Epub 2016 Mar 17. J Crohns Colitis. 2016. PMID: 26989194
-
A Dedicated Pregnancy Clinic Improves Reproductive Knowledge in Inflammatory Bowel Disease.Dig Dis Sci. 2022 Sep;67(9):4269-4277. doi: 10.1007/s10620-021-06998-0. Epub 2021 May 3. Dig Dis Sci. 2022. PMID: 33939151
-
Does the level of reproductive knowledge specific to inflammatory bowel disease predict childlessness among women with inflammatory bowel disease?Can J Gastroenterol Hepatol. 2015 Mar;29(2):95-103. doi: 10.1155/2015/715354. Can J Gastroenterol Hepatol. 2015. PMID: 25803020 Free PMC article.
-
Fertility and Assisted Reproductive Technologies Outcomes of Women with Non-surgically Managed Inflammatory Bowel Diseases: A Systematic Review.J Crohns Colitis. 2023 Apr 19;17(4):614-632. doi: 10.1093/ecco-jcc/jjac170. J Crohns Colitis. 2023. PMID: 36322700
-
Management of inflammatory bowel disease in pregnancy.J Crohns Colitis. 2012 Sep;6(8):811-23. doi: 10.1016/j.crohns.2012.04.009. Epub 2012 May 16. J Crohns Colitis. 2012. PMID: 22595185 Review.
Cited by
-
Health Maintenance and Unique Health Needs of the Perimenopausal and Postmenopausal Woman with Inflammatory Bowel Disease.Dig Dis Sci. 2025 Jul 8. doi: 10.1007/s10620-025-09199-1. Online ahead of print. Dig Dis Sci. 2025. PMID: 40627279 Review.
-
Dietary Intake of Pregnant Women with and without Inflammatory Bowel Disease in the United States.Nutrients. 2023 May 25;15(11):2464. doi: 10.3390/nu15112464. Nutrients. 2023. PMID: 37299427 Free PMC article.
-
IBD and Motherhood: A Journey through Conception, Pregnancy and Beyond.J Clin Med. 2023 Sep 25;12(19):6192. doi: 10.3390/jcm12196192. J Clin Med. 2023. PMID: 37834837 Free PMC article. Review.
-
Impact of sex and socioeconomic status on the likelihood of surgery, hospitalization, and use of medications in inflammatory bowel disease: a systematic review and meta-analysis.Syst Rev. 2024 Jun 24;13(1):164. doi: 10.1186/s13643-024-02584-3. Syst Rev. 2024. PMID: 38915086 Free PMC article.
-
Pregnancy in Patients with Inflammatory Bowel Disease: A Narrative Review.Visc Med. 2025 Apr;41(2):53-63. doi: 10.1159/000539158. Epub 2024 Jun 10. Visc Med. 2025. PMID: 40201110 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical